Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.470
-0.250 (-5.30%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $21.47 million as of October 2, 2026. Its market cap has increased by 404.99% in one year.
Market Cap
21.47M
Enterprise Value
12.70M
1-Year Change
404.99%
Ranking
Category
Stock Price
$4.47
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $21.47M, a decrease of -77.90%. That is a compound annual growth rate of -26.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 21.47M | 77.38% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 23.35M |
| Polyrizon | 23.34M |
| NextCure | 23.30M |
| Cocrystal Pharma | 22.06M |
| TScan Therapeutics | 21.72M |
| Radiopharm Theranostics | 21.10M |
| SeaStar Medical Holding | 20.67M |
| Estrella Immunopharma | 20.36M |